Literature DB >> 6171789

Electrophysiologic properties of cimetidine in man.

L Gould, C V Reddy, B K Singh, B Zen.   

Abstract

Severe bradycardia has been reported with the use of cimetidine. This observation has been explained by histamines' known action in increasing the contraction rate of the spontaneously beating right atrium, strips of ventricular muscle, and whole heart of guinea pigs. Histamine can also produce cardiac arrhythmias in animals. There is evidence for H2 receptors in the heart. Black and his associates have shown that the characteristic effect of histamine on isolated guinea pig atrium could be selectively blocked by anti-H2 drugs. Thus cimetidine probably can produce a sinus bradycardia by blocking the H2-receptor site in the heart. Recently Engel and Luck reported that 300 mgs of intravenously administered cimetidine did not affect heart rate, sinus node recovery time, or sinoatrial conduction time. These workers concluded that there is insufficient evidence to demonstrate that cimetidine caused appreciable sinus node dysfunction in man. In view of the disparity in these reports, we investigated the effects of 300 mgs of intravenously administered cimetidine on the human conduction system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171789     DOI: 10.1111/j.1540-8159.1981.tb03667.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  H2-blocker modulates heart rate variability.

Authors:  T Ooie; T Saikawa; M Hara; H Ono; M Seike; T Sakata
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Negative inotropic effect of some H2-receptor antagonists on the isolated human atria.

Authors:  G Coruzzi; E Poli; F Fesani; D Medici; G Bertaccini
Journal:  Experientia       Date:  1983-11-15

3.  H2-receptor antagonism is not pro-arrhythmic in a chronic canine model.

Authors:  A C Uprichard; D W Harron
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.